HomeCompareNSTG vs O

NSTG vs O: Dividend Comparison 2026

NSTG yields 1899.34% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NSTG wins by $11.17M in total portfolio value
10 years
NSTG
NSTG
● Live price
1899.34%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.20M
Annual income
$104,612.63
Full NSTG calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — NSTG vs O

📍 NSTG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNSTGO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NSTG + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NSTG pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NSTG
Annual income on $10K today (after 15% tax)
$161,443.49/yr
After 10yr DRIP, annual income (after tax)
$88,920.74/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, NSTG beats the other by $84,583.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NSTG + O for your $10,000?

NSTG: 50%O: 50%
100% O50/50100% NSTG
Portfolio after 10yr
$5.62M
Annual income
$54,857.69/yr
Blended yield
0.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

NSTG
Analyst Ratings
7
Buy
6
Hold
Consensus: Buy
Price Target
$21.50
+20317.9% upside vs current
Range: $15.00 — $28.00
Altman Z
-5.5
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NSTG buys
0
O buys
0
No recent congressional trades found for NSTG or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNSTGO
Forward yield1899.34%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.1%
Portfolio after 10y$11.20M$34.2K
Annual income after 10y$104,612.63$5,102.74
Total dividends collected$7.86M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$21.50$64.00

Year-by-year: NSTG vs O ($10,000, DRIP)

YearNSTG PortfolioNSTG Income/yrO PortfolioO Income/yrGap
1← crossover$105,667$94,966.76$10,818$608.16+$94.8KNSTG
2$581,981$468,917.30$11,787$741.68+$570.2KNSTG
3$1,829,568$1,206,848.32$12,946$911.00+$1.82MNSTG
4$3,730,515$1,772,877.76$14,345$1,127.94+$3.72MNSTG
5$5,680,868$1,689,216.64$16,056$1,409.05+$5.66MNSTG
6$7,280,565$1,202,035.94$18,171$1,777.83+$7.26MNSTG
7$8,510,074$719,869.96$20,820$2,268.21+$8.49MNSTG
8$9,498,975$393,195.52$24,188$2,929.90+$9.47MNSTG
9$10,368,990$205,087.02$28,533$3,837.11+$10.34MNSTG
10$11,199,432$104,612.63$34,235$5,102.74+$11.17MNSTG

NSTG vs O: Complete Analysis 2026

NSTGStock

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Full NSTG Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this NSTG vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NSTG vs SCHDNSTG vs JEPINSTG vs KONSTG vs MAINNSTG vs STAGNSTG vs ADCNSTG vs NNNNSTG vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.